Subscribe to Newsletter

Ehab Atallah

Professor of Medicine and Section Head of Hematological Malignancies, Medical College of Wisconsin Division of Hematology and Oncology and Froedtert Hospital, Milwaukee, Wisconsin, USA.

Content by Ehab Atallah:

 Subspecialties Oncology

Maintaining Molecular Remission

| Ehab Atallah

CML patients in remission are eager to discontinue TKI treatment – but how can we be sure which will experience durable treatment-free remission?
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register

December Issue of The Pathologist